Repository logo
 
Publication

CITED2 and the modulation of the hypoxic response in cancer

dc.contributor.authorFernandes, Mónica T
dc.contributor.authorCalado, Sofia
dc.contributor.authorMendes-Silva, Leonardo
dc.contributor.authorBragança, José
dc.date.accessioned2020-09-14T08:45:05Z
dc.date.available2020-09-14T08:45:05Z
dc.date.issued2020
dc.description.abstractCITED2 (CBP/p300-interacting transactivator with Glu/Asp-rich C-terminal domain, 2) is a ubiquitously expressed protein exhibiting a high affinity for the CH1 domain of the transcriptional co-activators CBP/p300, for which it competes with hypoxia-inducible factors (HIFs). CITED2 is particularly efficient in the inhibition of HIF-1α-dependent transcription in different contexts, ranging from organ development and metabolic homeostasis to tissue regeneration and immunity, being also potentially involved in various other physiological processes. In addition, CITED2 plays an important role in inhibiting HIF in some diseases, including kidney and heart diseases and type 2-diabetes. In the particular case of cancer, CITED2 either functions by promoting or suppressing cancer development depending on the context and type of tumors. For instance, CITED2 overexpression promotes breast and prostate cancers, as well as acute myeloid leukemia, while its expression is downregulated to sustain colorectal cancer and hepatocellular carcinoma. In addition, the role of CITED2 in the maintenance of cancer stem cells reveals its potential as a target in non-small cell lung carcinoma and acute myeloid leukemia, for example. But besides the wide body of evidence linking both CITED2 and HIF signaling to carcinogenesis, little data is available regarding CITED2 role as a negative regulator of HIF-1α specifically in cancer. Therefore, comprehensive studies exploring further the interactions of these two important mediators in cancer-specific models are sorely needed and this can potentially lead to the development of novel targeted therapies.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.5306/wjco.v11.i5.260pt_PT
dc.identifier.issn2218-4333
dc.identifier.urihttp://hdl.handle.net/10400.1/14716
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherBaishideng Publishing Grouppt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectCancerpt_PT
dc.subjectCancer stem cellpt_PT
dc.subjectCBP/p300pt_PT
dc.subjectHypoxia-inducible factors 1αpt_PT
dc.subjectCITED2pt_PT
dc.titleCITED2 and the modulation of the hypoxic response in cancerpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage274pt_PT
oaire.citation.issue5pt_PT
oaire.citation.startPage260pt_PT
oaire.citation.titleWorld Journal of Clinical Oncologypt_PT
oaire.citation.volume11pt_PT
person.familyNameTeotónio Fernandes
person.familyNameCalado
person.familyNameMendes e Silva
person.familyNameBragança
person.givenNameMónica Alexandra
person.givenNameSofia
person.givenNameLeonardo
person.givenNameJosé
person.identifier.ciencia-idD21D-88F0-DBD1
person.identifier.ciencia-id7C1A-91BA-B6A0
person.identifier.ciencia-id7918-CF94-9CF4
person.identifier.ciencia-idAC1D-FA9D-F66F
person.identifier.orcid0000-0002-1206-1367
person.identifier.orcid0000-0001-5509-4145
person.identifier.orcid0000-0002-5989-637X
person.identifier.orcid0000-0001-9566-400X
person.identifier.ridK-2202-2016
person.identifier.ridK-8962-2018
person.identifier.scopus-author-id56426215600
person.identifier.scopus-author-id57201364200
person.identifier.scopus-author-id6602220001
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication4aeefcfb-528b-4067-95ed-fef9aacccebf
relation.isAuthorOfPublication950f7df3-f549-497f-9ace-8edd58a83e08
relation.isAuthorOfPublication155c8f72-bc3a-49da-8bbd-5480d8d312fa
relation.isAuthorOfPublication27334e02-e955-4939-b9b5-bdee5b5f9328
relation.isAuthorOfPublication.latestForDiscovery27334e02-e955-4939-b9b5-bdee5b5f9328

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
WJCO-11-260.pdf
Size:
7.62 MB
Format:
Adobe Portable Document Format